Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease

Ítems similars

• Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease
  per: Faubion, William A., et al.
  Publicat: (2017)
• Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn’s Disease: Results from IMAgINE 1 and IMAgINE 2
  per: Ruemmele, Frank M, et al.
  Publicat: (2018)
• Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance Therapy
  per: Motoya, Satoshi, et al.
  Publicat: (2018)
• Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
  per: Suzuki, Yasuo, et al.
  Publicat: (2017)
• Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
  per: Suzuki, Yasuo, et al.
  Publicat: (2017)